STRAUSS ROBERT C 4
4 · NOVEN PHARMACEUTICALS INC · Filed Jan 6, 2004
Insider Transaction Report
Form 4
STRAUSS ROBERT C
DirectorPresident, CEO & Chairman
Transactions
- Exercise/Conversion
Common Stock ($.0001 Par Value)
2004-01-05$6.18/sh+33,187$205,096→ 107,571 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-06−6,700→ 235,238 totalExercise: $6.18Exp: 2004-12-11→ Common Stock (6,700 underlying) - Exercise/Conversion
Common Stock ($.0001 Par Value)
2004-01-06$6.18/sh+6,700$41,406→ 81,084 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-01-05−33,187→ 241,938 totalExercise: $6.18Exp: 2004-12-11→ Common Stock (33,187 underlying) - Sale
Common Stock ($.0001 Par Value)
2004-01-05$16.00/sh−33,187$530,992→ 74,384 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2003.
- [F2]10% exercisable after 12/12/1998; 20% exercisable after 12/12/1999; 20% exercisable after 12/12/2000; 25% exercisable after 12/12/2001; 25% exercisable after 12/12/2002.